Viral Dynamics of the SARS-CoV-2 Omicron Variant in Pediatric Patients: A Prospective Cohort Study
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciad740 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Michelle Science und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Viral Load, Virus Shedding. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
There are limited data on the viral dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children. Understanding viral load changes over the course of illness and duration of viral shedding may provide insight into transmission dynamics to inform public health and infection-control decisions.
Methods
We conducted a prospective cohort study of children aged 18 years and younger with polymerase chain reaction–confirmed SARS-CoV-2 between 1 February 2022 and 14 March 2022. SARS-CoV-2 testing occurred on daily samples for 10 days; a subset of participants completed daily rapid antigen tests (RATs). Viral RNA trajectories were described in relation to symptom onset and resolution. The associations between both time since symptom onset/resolution and non-infectious viral load were evaluated using a Cox proportional hazards model.
Results
Among 101 children aged 2 to 17 years, the median time to study-defined non-infectious viral load was 5 days post–symptom onset, with 75% meeting this threshold by 7 days and 90% by 10 days. On the day of and day after symptom resolution, 43 (49%) and 52 (60%) of 87 had met the non-infectious thresholds, respectively. Of the 50 participants completing a RAT, positivity at symptom onset and on the day after symptom onset was 67% (16/24) and 75% (14/20). On the first day where the non-infectious threshold was met, 61% (n = 27/44) of participant RAT results were positive.
Conclusions
Children often met the study-defined non-infectiousness threshold on the day after symptom resolution. The RATs were often negative early in the course of illness and should not be relied on to exclude infection. Clinical Trials Registration. clinicaltrials.org; NCT05240183.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Public Health Ontario, Toronto, Ontario, Canada.
- Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
- Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada.
- Biostatistics Design and Analysis Unit, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
ORCID-Profile: Michelle Science
Zitieren
APA
Science, M., Orkin, J., Maguire, B., Bitnun, A., Bourns, L., Corbeil, A., Johnstone, J., Macdonald, L., Schwartz, K. L., Bruce Barrett, C., Reinprecht, J., Heisey, A., Nasso, S., Jüni, P., & Campigotto, A. (2024). Viral Dynamics of the SARS-CoV-2 Omicron Variant in Pediatric Patients: A Prospective Cohort Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad740
Vancouver
Science M, Orkin J, Maguire B, Bitnun A, Bourns L, Corbeil A, et al. Viral Dynamics of the SARS-CoV-2 Omicron Variant in Pediatric Patients: A Prospective Cohort Study. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad740
BibTeX
@article{Science2024,
author = {Science, Michelle and Orkin, Julia and Maguire, Bryan and Bitnun, Ari and Bourns, Laura and Corbeil, Antoine and Johnstone, Jennie and Macdonald, Liane and Schwartz, Kevin L and Bruce Barrett, Cindy and Reinprecht, Jessica and Heisey, Alice and Nasso, Stephanie and Jüni, Peter and Campigotto, Aaron},
title = {Viral Dynamics of the SARS-CoV-2 Omicron Variant in Pediatric Patients: A Prospective Cohort Study},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciad740}
}
EUVIMED